These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38836447)

  • 1. Spray vaccination with a Newcastle disease virus (NDV)-vectored infectious laryngotracheitis (ILT) vaccine protects commercial chickens from ILT in the presence of maternally-derived antibodies.
    Zeng Z; Wang Z; Wang X; Yao L; Shang Y; Feng H; Wang H; Shao H; Luo Q; Wen G
    Avian Pathol; 2024 Jul; ():1-7. PubMed ID: 38836447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M; Kumar S; Khattar SK; Gebreluul GT; Paldurai A; Samal SK
    Vaccine; 2014 Jun; 32(28):3555-63. PubMed ID: 24793943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a Recombinant Thermostable Newcastle Disease Virus (NDV) Expressing Glycoprotein gB of Infectious Laryngotracheitis Virus (ILTV) Protects Chickens against ILTV Challenge.
    Zeng Z; He Y; Wang Z; Yao L; Li L; Shang Y; Wang H; Zhang R; Shao H; Luo Q; Wen G
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X; Shao Y; Han Z; Sun J; Liu S
    Vet Microbiol; 2020 Nov; 250():108835. PubMed ID: 33011664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines.
    Zhao W; Spatz S; Zsak L; Yu Q
    Methods Mol Biol; 2016; 1404():89-101. PubMed ID: 27076292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
    Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
    Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The protection conferred against virulent Newcastle disease virus (vNDV) genotype VII by commercial double recombinant HVT vaccines and NDV live-attenuated vaccine as prime/boost vaccination regimens in commercial broiler chickens carrying maternally-derived antibodies (MDAs) against NDV.
    Ghanem IAE; Abdullatif TM; Hassanin O
    Avian Pathol; 2023 Aug; 52(4):251-263. PubMed ID: 37158499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection induced by infectious laryngotracheitis virus vaccines alone and combined with Newcastle disease virus and/or infectious bronchitis virus vaccines.
    Vagnozzi A; García M; Riblet SM; Zavala G
    Avian Dis; 2010 Dec; 54(4):1210-9. PubMed ID: 21313841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus.
    Tong GZ; Zhang SJ; Wang L; Qiu HJ; Wang YF; Wang M
    Avian Pathol; 2001 Apr; 30(2):143-8. PubMed ID: 19184888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early infection with Marek's disease virus can jeopardize protection conferred by laryngotracheitis vaccines: a method to study MDV-induced immunosuppression.
    Faiz NM; Cortes AL; Guy JS; Fletcher OJ; West M; Montiel E; Gimeno IM
    Avian Pathol; 2016 Dec; 45(6):606-615. PubMed ID: 27207594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge.
    Shao Y; Sun J; Han Z; Liu S
    Vaccine; 2018 Dec; 36(52):7975-7986. PubMed ID: 30448332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K; Lee DH; Criado MF; Balzli CL; Killmaster LF; Kapczynski DR; Swayne DE
    Vaccine; 2018 Oct; 36(43):6361-6372. PubMed ID: 30241684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newcastle disease virus (NDV) recombinant expressing Marek's disease virus (MDV) glycoprotein B significantly protects chickens against MDV and NDV challenges.
    He L; Spatz S; Dunn JR; Yu Q
    Vaccine; 2023 Sep; 41(40):5884-5891. PubMed ID: 37598026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
    Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
    Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection Efficacy of the Infectious Laryngotracheitis (ILT) Serva CEO Vaccine Strain in Broiler Chickens Under Different Vaccination Coverage Conditions.
    Assen AM; Gerber PF; Walkden-Brown SW
    Avian Dis; 2023 Jun; 67(2):160-169. PubMed ID: 37556295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.